New York - The United Nations Development Programme (UNDP) and the Global Fund strengthened their partnership with additional funding of US$ 143 million to help scale up the fight against HIV in Zimbabwe.
HIV remains a major public health challenge in Zimbabwe with 1.4 million people living with HIV at the end of 2015. Even though the country has seen one of the sharpest declines in HIV prevalence in the region, at 15 per cent it remains among the highest HIV prevalence rates in the world.
The HIV grant aims to increase access to HIV treatment, with a particular focus on the elimination of mother-to-child transmission of HIV, expanding HIV testing and counseling services, and scale up of prevention for adolescents and in and out of school youth.
New York - The United Nations Development Programme (UNDP) and the Global Fund signed a US$30 million grant to reduce new HIV infections in Angola, while also increasing antiretroviral therapy coverage and ensuring better adherence to treatment. The grant was signed in the presence of the Angolan Minister of Health, Dr. Luís Gomes Sambo and other key representatives.
Even though the prevalence of HIV among adults aged 15 to 49 years in Angola has remained low at under 2.5% of the population, significant challenges remain around the elimination of mother-to-child transmission, adherence to antiretroviral treatment, prevention for young people and the inclusion of key populations in the National Strategy on HIV and AIDS.
Monday 18 July 2016 • 12.30PM – 2.30PM • Durban International Convention Centre, Room 12 • AIDS 2016, 21st International AIDS Conference • Durban, South Africa
Four years after the Global Commission on HIV and the Law released its report on the impact of laws, policies and practices on those living with and most vulnerable to HIV, UNDP is taking stock of its recommendations on the AIDS response. This satellite session offers the opportunity for participants to:
New York - The United Nations Development Programme (UNDP) and the Global Fund signed a US$8.7 million grant to scale up HIV prevention measures and treatment for people most at risk of contracting the virus in Afghanistan, including injecting drugs users and prisoners.
Though HIV infection rates across the general population in Afghanistan are low, the epidemic continues to spread among key populations at higher risk of HIV. For example, injecting drug use is a major driver of HIV infections in Afghanistan, a country that is also the world's leading producer of opium and heroin.
A combination of injecting practices involving the use of non-sterile equipment, high-risk sexual behaviour, punitive policies and stigma towards people who inject drugs are fuelling the epidemic. The most recently available drug use survey showed that eight per cent of the population aged 15-64 is dependent on drugs, with significant increases in the number of people who use opium and heroin.
Transgender rights received unprecedented recognition in Asia and across the world in 2015. However, a new Series published in The Lancet today reveals that public recognition has yet to translate into a concerted effort to support and improve the health and lives of transgender people.
The Series was launched at the World Professional Association for Transgender Health's (WPATH) 24th Biennial Scientific Symposium in Amsterdam. It was compiled with input from members of the transgender community and provides an assessment of transgender health worldwide.
The global study points to major gaps in our understanding of transgender health. According to the authors, there is a failure to recognize gender diversity in public health efforts, however, it is noted there is enough information about this marginalized group to act now.